Approval

Approval  ·  Weekly Digest - 13 December to 19 December 2025
Enhertu plus pertuzumab approved in the US as first new treatment in a decade for the 1st-line treatment of patients with HER2-positive metastatic breast cancer

Weekly Digest – December 2025 Weekly Digest – December 2025 15 December 2025: Enhertu plus pertuzumab approved in the US as first new treatment in a decade for the 1st-line treatment of patients with HER2-positive metastatic breast cancer The US […]

by Sandhya Ramalingam

Continue Reading
Approval  ·  Weekly Digest - 13 December to 19 December 2025
AstraZeneca Pharma India gets CDSCO nod for Datopotamab deruxtecan for treating metastatic breast cancer

Weekly Digest – December 2025 Weekly Digest – December 2025 18 December 2025: AstraZeneca Pharma India gets CDSCO nod for Datopotamab deruxtecan for treating metastatic breast cancer AstraZeneca Pharma India Ltd. announced that the Central Drugs Standard Control Organisation (CDSCO) […]

by Sandhya Ramalingam

Continue Reading